Navigation Links
Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights
Date:8/5/2008

rena previously settled in June 2006 a similar disagreement with the other warrant holder.

Cash, cash equivalents and short-term investments totaled $272.2 million at June 30, 2008. Approximately 73.9 million shares of common stock were outstanding at June 30, 2008.

Arena's Recent and Second Quarter Highlights

-- Completed BLOSSOM enrollment with 4,008 obese and overweight patients in about 95 clinical sites in the United States. BLOSSOM is a one-year, randomized, double-blind, placebo-controlled clinical trial. BLOSSOM and BLOOM comprise Arena's pivotal trial program evaluating lorcaserin's safety and efficacy for the treatment of obesity.

-- Reported positive Phase 1b clinical trial results of APD791, Arena's internally discovered oral drug candidate intended for the treatment of arterial thrombosis and other related conditions. This Phase 1b trial was a randomized, double-blind, placebo-controlled multiple-ascending dose trial in 50 healthy volunteers.

-- Dr. Thomas Roth of Henry Ford Hospital presented data from Arena's positive Phase 2a clinical trial of APD125 for the treatment of insomnia in an oral presentation at the SLEEP 2008 22nd Annual Meeting of the Associated Professional Sleep Societies. When compared to placebo, APD125 significantly improved endpoints measuring improvements in sleep maintenance without any next day impairment of cognition or coordination.

-- Initiated a Phase 2b clinical trial of APD125, Arena's internally discovered oral drug candidate intended to reduce insomnia symptoms and improve sleep maintenance and quality. This is a randomized, double-blind, placebo-controlled subjective study that is expected to enroll approximately 675 patients in about 65 clinical sites in the United States.

-- Taisho Pharmaceutical Co., Ltd. initiated a Phase 1 clinical trial of a drug candidate under a GPCR-focused partnership to develop compounds to treat psychiatric disorders. The drug candidate is a n
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Arena Pharmaceuticals to Report Second Quarter 2008 Financial Results and to Host Conference Call and Webcast on Tuesday, August 5, 2008
2. Arena Pharmaceuticals to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference
3. ThreeWire Expands Presence in the Pharmaceutical Arena
4. Arena Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
5. Arena Pharmaceuticals Announces First Quarter 2008 Financial Results
6. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
7. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results
8. Arena Pharmaceuticals to Report Fourth Quarter and Full Year 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, February 27, 2008
9. Arena Pharmaceuticals to Present at the BIO CEO & Investor Conference
10. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Second Generation Niacin Receptor Agonist Under Its Collaboration With Merck & Co., Inc.
11. Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material, Including Lorcaserin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... OR (PRWEB) October 20, 2014 Local ... participate in an investigational study of donor stem cells ... in stem cell therapy and has performed clinical stem ... this study is to determine if a single injection ... affected joints can help reduce pain and inflammation in ...
(Date:10/19/2014)... The Asia-Pacific Bromine Market report ... with analysis and forecast of revenue. , Browse ... Market report, to get an idea of the ... of the segmentation in the Asia-Pacific bromine market, ... , http://www.micromarketmonitor.com/market/asia-pacific-bromine-6741503144.html , Bromine is ...
(Date:10/19/2014)... Asian Orthopedic braces and support systems report defines and segments ... revenue. The Orthopedic braces and support systems market in Asia ... at a developing CAGR of 4.4% from 2013 to 2018. ... and support systems market, to get an idea of the ... segmentation of orthopedic braces and support systems market in the ...
(Date:10/18/2014)... October 18, 2014 The Asia-Pacific ... and segments the bio-based advanced phase change material ... revenue. , Browse through the TOC of the ... to get an idea of the in-depth analysis ... segmentation in the Asia-Pacific bio-based advanced phase change ...
Breaking Biology Technology:Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 3The Asian Orthopedic braces and support systems market is estimated to grow to around $416.5 million by 2018 - New Report by MicroMarket Monitor 2The Asian Orthopedic braces and support systems market is estimated to grow to around $416.5 million by 2018 - New Report by MicroMarket Monitor 3The Asian Orthopedic braces and support systems market is estimated to grow to around $416.5 million by 2018 - New Report by MicroMarket Monitor 4The Asia-Pacific Bio-based Advanced Phase Change Materials Market is estimated to grow to $39.8 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific Bio-based Advanced Phase Change Materials Market is estimated to grow to $39.8 million by 2018 - New Report by MicroMarket Monitor 3The Asia-Pacific Bio-based Advanced Phase Change Materials Market is estimated to grow to $39.8 million by 2018 - New Report by MicroMarket Monitor 4
... YORK, May 19, 2011 Reportlinker.com ... report is available in its catalogue: ... (MEMs) Devices Industry ... report analyzes the worldwide markets for ...
... new gene expression technique adapted for single molecule sequencing ... (OSC) to accurately and quantitatively measure gene expression levels ... which pairs RIKEN,s Cap Analysis of Gene Expression (CAGE) ... Helicos BioSciences Corporation, opens the door to the detailed ...
... 2011 Oppenheimer & Co. Inc., a unit of Oppenheimer ... join the firm as Managing Director in the Healthcare group ... drive its life science business. He will report to Brian ... Since 2003, Matthias had worked at JMP Securities, ...
Cached Biology Technology:Global Micro-Electromechanical Systems (MEMs) Devices Industry 2Global Micro-Electromechanical Systems (MEMs) Devices Industry 3Global Micro-Electromechanical Systems (MEMs) Devices Industry 4Global Micro-Electromechanical Systems (MEMs) Devices Industry 5Global Micro-Electromechanical Systems (MEMs) Devices Industry 6Global Micro-Electromechanical Systems (MEMs) Devices Industry 7Global Micro-Electromechanical Systems (MEMs) Devices Industry 8Global Micro-Electromechanical Systems (MEMs) Devices Industry 9Global Micro-Electromechanical Systems (MEMs) Devices Industry 10Global Micro-Electromechanical Systems (MEMs) Devices Industry 11Global Micro-Electromechanical Systems (MEMs) Devices Industry 12Global Micro-Electromechanical Systems (MEMs) Devices Industry 13Global Micro-Electromechanical Systems (MEMs) Devices Industry 14Global Micro-Electromechanical Systems (MEMs) Devices Industry 15Global Micro-Electromechanical Systems (MEMs) Devices Industry 16Global Micro-Electromechanical Systems (MEMs) Devices Industry 17Global Micro-Electromechanical Systems (MEMs) Devices Industry 18Global Micro-Electromechanical Systems (MEMs) Devices Industry 19Global Micro-Electromechanical Systems (MEMs) Devices Industry 20Global Micro-Electromechanical Systems (MEMs) Devices Industry 21Global Micro-Electromechanical Systems (MEMs) Devices Industry 22Global Micro-Electromechanical Systems (MEMs) Devices Industry 23Global Micro-Electromechanical Systems (MEMs) Devices Industry 24HeliScopeCAGE: A new gene expression analysis technique on a single molecule sequencer 2
(Date:10/15/2014)... spreading rapidly and to an unexpected extent. The outbreak ... and the virus shows a new disease dynamic in ... this reason, the German National Academy of Sciences Leopoldina, ... and the Union of the German Academies of Sciences ... epidemic today. , In the statement the academies call ...
(Date:10/15/2014)... Rosenstiel Award for Distinguished Work in Biomedical Science by ... of genomic instability and its implications for the immune ... to win the Rosenstiel Award; the first, Rod McKinnon, ... the Charles A. Janeway Professor of Pediatrics and Professor ... at the Howard Hughes Medical Institute at Boston Children,s ...
(Date:10/14/2014)... in Cancer Research shows SIRT6—a protein known ... promote the development of skin cancers by turning on ... sun-damaged skin cells. , Previously considered protective, SIRT6 is ... that help regulate genomic stability and prevent some of ... DNA damage, which can lead to cancer. This study, ...
Breaking Biology News(10 mins):Academies call for consequences from the Ebola virus epidemic 2Academies call for consequences from the Ebola virus epidemic 3Academies call for consequences from the Ebola virus epidemic 4Academies call for consequences from the Ebola virus epidemic 5Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2
... crops account for almost 50% of crop sales in ... to ensure good quality. But more information is needed ... climatic changes so that management practices such as irrigation ... to generalize because of variations in crops, planting densities, ...
... the Marfan syndrome is that the aorta may split ... if the syndrome is diagnosed and treated in good ... rzteblatt International (Dtsch Arztebl Int 2008; 105[27]: 483-91), ... School and his coauthors present additional studies on Marfan ...
... Travel America,s highways or drive down any city ... From small, manicured beds of flowers maintained by ... byways, roadside gardens are taking root. Aside ... roadside beautification, including landscaping and gardens, can help ...
Cached Biology News:Digital cameras, remote satellites measure crop water demand 2New roadside beautification concept studied 2
... positive control for ChIP assays. Efficient fixation ... is a crucial step for the Chromatin-immunoprecipitation ... probably the most important parameter. Two major ... be taken into account: first, an excess ...
Mouse monoclonal [M2II-12] to MRP2 ( Abpromise for all tested applications). entrezGeneID: 1244 SwissProtID: Q92887...
The Programmable MP-5000P-F Power Supply can be applied for any Microfluidic application....
Rab GDP dissociation inhibitor beta...
Biology Products: